Impact on Visual Acuity in Neovascular Age Related Macular Degeneration (nAMD) in Europe Due to COVID-19 Pandemic Lockdown

This is a retrospective, multicenter study of consecutive patients with nAMD scheduled for visit and/or treatment an intravitreal injection (IVI) during the 3 months before lockdown in Ophthalmology Departments six centers Europe.The was conducted on 546 patients, which 55.13% were females, almost 100% White/Caucasian race, and 71.53% presented type 1 macular neovascularization (NVM). A total 62.82% (343 patients) that clinic visits quarantine did not attend either to or lockdown. The mean number injections significantly reduced. followed by significant reduction best-corrected visual acuity (BCVA) between (mean BCVA 60.68 ± 19.77 letters) 6 after 56.98 22.59 letters). Patients better ones showing neovascular activity more likely their IVI treatments. COVID-19 pandemic have led decrease treatments nAMD, evidencing vision loss at months.